Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

COSMOS Pharmaceutical (3349.T)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2021-08-2099158750Neutral
2022-03-2578658250Neutral
2022-08-1073007750Neutral
2023-02-0864807000Neutral
2023-09-207855-No Rating
2023-10-3075458235Neutral
2023-12-0883458570Neutral
2024-01-1379108415Neutral
2024-04-1370207720Neutral
2024-06-1164887205Neutral
2024-07-1364087025Neutral
2024-09-1173197400Neutral
2024-09-2772527710Neutral
2024-10-1273207870Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.